A recent study indicates that individuals who discontinue popular GLP-1 drugs like Mounjaro or Wegovy may regain reduced body mass much more quickly than those who stop conventional diet and exercise programs.
Research printed in a prominent health publication points out that while obese people can lose substantial amounts of their total mass while undergoing treatment, the weight comes back at an average rate of nearly a kilo each month once they quit.
"Users buying such medications need to be cognizant of the risk of quick rebound weight gain when the therapy is stopped," stated expert Dr. Susan Jebb.
Such speed of regain implies a reversion to starting mass in about one and a half years.
Weighing Approaches
The analysis, which looked at 37 of trials involving over 9,000 of participants, contrasted the outcomes of GLP-1 agonists with older methods.
Scientists note that individuals who shed pounds through diet and exercise typically see a more gradual creep back—around 0.1 kg a month—once they finish.
Explaining the Fast Rebound
Experts believe the mode of action of the jabs accounts for the accelerated weight return.
GLP-1 drugs mimic a natural hormone called GLP-1, which helps regulate hunger.
"Sustained high doses of the hormone levels several times higher than normal might result in the system to produce less of its own natural GLP-1, and may also lessen sensitivity to its effects," explained Dr. Adam Collins, a nutrition researcher.
"Stopping of this medication results in hunger is unsuppressed, making overeating a significant risk."
A Lifelong Issue?
Health authorities advise the injections for people with weight-linked health risks, accompanied by prescribed lifestyle changes.
Many experts contend that, due to the likelihood of weight regain, the treatment is often ongoing.
This view is supported by pharmaceutical companies, who note that the results "highlight the long-term nature of excess weight," similar to managing conditions like high blood pressure.
User Accounts
Users who have come off the jabs explain a intense return of cravings.
"I experienced something flipping and you're instantly ravenous," recalled an individual.
This difficulty is exacerbated if individuals have not adopted sustainable lifestyle or habit changes during therapy.
Widespread Interest
Survey data indicate that millions of people in the UK have used these injections in the past year, with demand being substantial.
- Adoption is more common among females than men.
- The 40s and 50s age group shows the highest level of interest.
- A large proportion access the medications through private prescriptions rather than the NHS.
Ultimately, experts emphasize that while these medications are powerful agents for weight loss, they are not a standalone solution and lasting health benefits hinges on combined lifestyle support.
